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Van Dijk, Gertjan, Todd E. Thiele, Jamie C. K. Dona- 
hey, L. Arthur Campfield, Francoise J. Smith, Paul 
Burn, Ilene L. Bernstein, Stephen C. Woods, and Randy 
J. Seeley. Central infusions of leptin and GLP-l-(7-36) 
amide differentially stimulate c-FL1 in the rat brain. Am. J. 
Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): 
R1096-RllOO, 1996.-Recently, glucagon-like peptide-1-(7- 
36) amide (GLP-1) and leptin have been implicated in the 
regulation of food intake. In the present study, we compared 
the effects of third ventricular administration (i3vt) of leptin 
(3.5 ug) and GLP-1 (10.0 ug) on short-term food intake and 
c-Fos-like immunoreactivity (c-FLI) in hypothalamic, limbic, 
and hindbrain areas in the rat. Relative to controls, infusion 
of leptin or GLP-l(3 h before lights off”) significantly reduced 
food intake over the first 2 h in the dark phase (53 and 63%, 
respectively). In different rats, infusion of leptin or GLP-1 
elevated c-FL1 in the paraventricular hypothalamus and 
central amygdala. Furthermore, leptin selectively elevated 
c-FL1 in the dorsomedial hypothalamus, whereas GLP-1 
selectively elevated c-FL1 in the nucleus of the solitary tract, 
area postrema, lateral parabrachial nucleus, and arcuate 
hypothalamic nucleus. The fact that most of the c-FL1 after 
leptin or GLP-1 administration was observed in separate 
regions within the central nervous system (CNS) suggests 
different roles for leptin and GLP-1 in the CNS regulation of 
food intake and body weight. 
food intake; body weight; hypothalamus; amygdala; caudal 
brain stem 
FOODINTAKEANDBODYWEIGHT areregulatedatthelevel 
of the central nervous system (CNS). Recently, two 
peptides, leptin, secreted from white adipose tissue (16, 
3 l), and glucagon-like peptide-1-( 7-36) amide (GLP- 
l), secreted from the distal portion of the gut (lZ), have 
been implicated in the CNS control of food intake and 
body weight. Circulating (2, 15) and central (22) levels 
of leptin correlate well with body adiposity, and central 
as well as peripheral administration of synthetic leptin 
reduces food intake and body weight (1, 5, 19, 29). 
GLP-1 is an incretin factor (8, 17), secreted from the L 
cells when nutrients enter the gastrointestinal tract (7, 
10, 20). GLP-1 is also secreted by neurons in the CNS 
(9, 11, 25>, and administration of GLP-1 into the third 
ventricle (i3vt) of rats reduces food intake (27). Given 
the different physiological characteristics of the two 
peptides, we hypothesized that the reductions in food 
intake after i3vt leptin and GLP-1 administration 
represent different mechanisms and sites of action. 
Therefore, we chose doses of each peptide that cause 
similar reductions of food intake and then used c-Fos 
immunohistochemistry to assess increases in neural 
activity in limbic, hypothalamic, and hindbrain regions 
after administration of these doses in the rat. 
MATERIALS AND METHODS 
AnimaZ preparation. Male Long-Evans rats weighing be- 
tween 300 and 400 g were individually housed in stainless 
steel hanging cages and maintained on a 12:12-h light-dark 
cycle. Pelleted chow and water were continuously available 
(except where noted). Under Equithesin (3.3 ml/kg ip) anesthe- 
sia, rats (n = 30) were implanted with 21-gauge stainless- 
steel cannulas (Plastics One, Roanoke, VA) aimed at the third 
ventricle. With bregma and lambda at the same vertical 
coordinate, cannulas were placed directly on the midline, 2.3 
mm posterior to bregma and 7.8 mm ventral to dura (18), and 
fixed to the skull with anchor screws and dental acrylic. The 
cannulas were fitted with removable obturators that ex- 
tended 0.5 mm beyond the tip of the guide cannula. After 
surgery, each rat was given 0.15 ml each of Chloromycetin 
(100 mg/ml SC) and gentamicin (40 mg/ml ip) prophylactically. 
One week later, cannula placements were confirmed by 
administration of 10 ng angiotensin II in saline. Animals that 
did not drink 5 ml of water within 60 min were not used (n = 
2). Continuing rats were allowed to recover for at least an 
additional 2 wk, during which time they all had returned to 
above presurgical weights and were handled twice daily for 
adaptation to the experimental procedures. 
Assessment of food consumption. On 2 experimental days, 
food was removed 3 h before lights off and rats (n = 12) were 
weighed. On the first experimental day, rats were divided into 
two groups matched for body weight (n = 6 each). One group 
was infused with synthetic cerebrospinal fluid (s-CSF) and 
the other was infused with GLP-1 (10.0 ug dissolved in 
s-CSF; American Peptide, Sunnyvale, CA). After 3 recovery 
days, three randomly assigned rats from each group were 
infused with leptin (3.5 ug dissolved in s-CSF). Leptin (at 
least 90% pure) was harvested from an expression system in 
which recombinant DNA of the human leptin gene was 
overexpressed in Escherichia coli (for details, see Ref. 1). For 
infusion, the obturator was removed and a 26-gauge infusion 
cannula connected to PE-20 infusion tubing was inserted into 
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the guide cannula. This infusion cannula extended 1.0 mm 
beyond the tip of the guide cannula. Solutions (3.5 ul) were 
manually infused with a Hamilton syringe over 60 s. Immedi- 
ately after infusion, the obturator was replaced. Food was 
weighed and returned to the cage 1 h later, and intake was 
assessed hourly until 2 h into the dark period. 
c-Fos-like immunoreactivity procedures. The remaining 
rats (n = 16) were infused during a 2-h window ending 3 h 
before lights off. Rats were divided into three groups matched 
for body weight, and animals in each group were infused with 
one of the three solutions used in the previous experiment 
(leptin, n = 5; GLP-1, n = 5; vehicle, n = 6). Two hours later, 
rats were anesthetized with Equithesin (3.3 ml/kg ip) and 
transcardially perfused with isotonic phosphate-buffered sa- 
line followed by 4% paraformaldehyde in 0.1 M phosphate 
buffer. Brains were removed and postfixated for -24 h and 
then processed for c-Fos-like immunoreactivity (c-FLI). An 
additional nonimplanted group was handled like the other 
groups throughout the experiment and served as a control for 
stress-induced c-FL1 (n = 3). Seventy-five-micrometer slices 
were cut from brains with a vibrotome. Coronal sections were 
taken from the forebrain. Horizontal slices were made from 
the hindbrain to allow visualization of the rostrocaudal 
extent of the nucleus of the solitary tract (NTS) and the 
parabrachial nucleus (PBN). Tissues were prepared for c-FL1 
according to methods described elsewhere (25). Camera lu- 
cida drawings of c-FLI-positive brain structures were pre- 
pared by an experimenter naive to group treatments. Particu- 
lar care was taken to score different structures (randomly 
selected from left or right hemisphere) in the same plane. 
With all other structures, drawings were made in an area of 
-0.38 mm2 and were scored by blind raters who recorded the 
number and location of c-FL1 nuclei. Scores across raters 
were averaged for statistical analyses. 
Data analyses. Differences between the groups in food 
intake and c-FL1 in response to drug infusion were analyzed 
with one-way analysis of variance (ANOVA). Separate 
ANOVAs were performed on data collected from each brain 
structure. When significant differences were found, post hoc 
analyses were conducted using Student’s t-tests. In all cases, 
P < 0.05 (two-tailed) indicated statistical significance. 
RESULTS 
Effects of leptin and GLP-1 on food consumption. 
Cumulative food intake in rats over a 4-h period (2 h in 
the dark phase) after i3vt infusion of leptin, GLP-1, or 
s-CSF was 0.7 _ . + 0 2, 0.5 ? 0.1, and 1.4 ? 0.2 g/l00 g 
body wt, respectively. ANOVA revealed a significant 
drug effect [F(2,15) = 9.671. Post hoc tests revealed 
that, whereas both leptin and GLP-1 produce signifi- 
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group, food intakes were not different between leptin 
and GLP-1. 
Effects of leptin and GLP-1 on c-FLI. Data from 
c-FLI-positive forebrain and hindbrain structures are 
depicted in Fig. 1, A and B, respectively. Representative 
photomicrographs of the paraventricular (PVH), the 
dorsomedial (DMH), and the arcuate (Arc) regions of 
the hypothalamus, the central nucleus of the amygdala 
(CeA), and the NTS are depicted in Fig. 2. Relative to 
the s-CSF and noninfused groups, both leptin and 
GLP-1 caused increased c-FL1 in the PVH and the CeA. 
Leptin induced increased c-FL1 in the DMH, whereas 
GLP-1 induced c-FL1 in the Arc, the area postrema 
(AP), NTS, and 1 t a era1 PBN (l-PBN). ANOVAs revealed 
that there were significant drug effects on c-FL1 in PVH 
[F(3,15) = 11.051, DMH [F(3,15) = 21.101, Arc [F(3, 
15) = 6.861, and CeA [F(3,15) = 56.441 in the forebrain. 
Post hoc tests comparing control groups (s-CSF and 
noninfused) to drug-treated groups revealed that both 
leptin and GLP-1 caused increased c-FL1 in the PVH 
and the CeA, that only leptin increased c-FL1 in the 
DMH, and that only GLP-1 increased c-FL1 in the Arc. 
c-FL1 in the CeA was significantly greater after GLP-1 
than after leptin. In the hindbrain, ANOVAs revealed 
significant drug effects on c-FL1 in AP [F(3,15) = 
61.83)], NTS [F(3,15) = 69.411, and l-PBN [F(3,15) = 
78.101. Post hoc tests comparing control groups to 
drug-treated groups indicated that GLP-1 significantly 
increased c-FL1 in the AP, NTS, and l-PBN. 
DISCUSSION 
The present results confirm that i3vt administration 
of leptin and GLP-1 each causes a reduction in food 
intake over 2 h in the dark phase. Thus the results are 
consistent with the recent reports that leptin (1, 5, 19, 
29) and GLP-1 (27) suppress food intake by actions 
directly in the CNS. Importantly for consideration of 
the c-FL1 data, the selected doses of leptin (3.5 ug) and 
GLP-1 (10.0 ug) reduced food intake comparably (53 
and 63%, respectively). 
The present results demonstrate for the first time 
that i3vt administrations of leptin and GLP-1 elevate 
c-FL1 in distinct areas in the CNS. Only GLP-1 caused 
elevation of c-FL1 in hindbrain regions (NTS, l-PBN, 
and AP) and the Arc, and only leptin caused elevation of 
c-FL1 in the DMH. Furthermore, both leptin and GLP-1 
caused elevation of c-FL1 in the PVH and the CeA. The 
NTS L-PBN 
Fig. 1. Mean ( + SE) c-Fos-like immunoreactivity 
(c-FLI)-positive nuclei in forebrain structures (A): 
the paraventricular (PVH), the dorsomedial 
(DMH), and the arcuate (Arc) nuclei of the hypo- 
thalamus and the central amygdala (CeA) after 
infusion of leptin, glucagon-like peptide-l-(7-36) 
amide (GLP- l), or synthetic cerebrospinal fluid. 
B: c-FLI-positive nuclei in the hindbrain struc- 
tures: the area postrema (AP), the nucleus of the 
solitary tract (NTS), and the lateral parabrachial 
nucleus (l-PBN). *Significant at P < 0.001 rela- 
tive to controls (s-CSF or noninfused); + signifi- 
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elevated c-FL1 in the CeA, which mainly appeared in 
the lateral CeA (1-CeA), was more pronounced after 
GLP-1 than leptin, Similar overall c-FL1 values were 
obtained in the PVH after administration of leptin and 
GLP-1. The localization of c-FL1 within the PVH ap- 
peared to be, for the most part, in the medial parvocel- 
lular subdivision. 
The receptor for leptin has recently been cloned, and 
preliminary reports suggest that central leptin recep- 
tors are localized within the hypothalamus and the 
choroid plexus (26). This is consistent with the elevated 
c-FL1 in the PVH and DMH as well as the dense c-FL1 
along the ventricular walls after leptin administration 
(see Fig. 22M; arrow). So, although c-FL1 in a region does 
not necessarily imply that there is a direct action of the 
treatment on that region of the CNS, the present data 
are consistent with a receptor-mediated role for leptin 
in the integration of food intake and body weight in 
hypothalamus and possibly limbic regions as well. 
Messenger RNA transcripts encoding for preprogluca- 
gon precursors have been found in the NTS (6), and 
GLP-1 binding sites have been localized in many brain 
areas, including those that expressed GLP-l-induced 
c-FL1 in the present experiment (4, 24, 28). Thus it is 
possible that GLP-1 is involved in relaying visceral 
information at the level of the NTS and that secondary 
ascending fiber systems projecting from the NTS acti- 
vate the c-FLI-positive areas identified in the present 
study (14). Because solutions administered i3vt readily 
gain access to the hindbrain (21), it is possible that i3vt 
administration of GLP-1 stimulated neural activity at 
all levels of this ascending pathway in the hindbrain. 
The endogenous signals that are responsible for stimu- 
lating central GLP-1 secretion are not known to date. 
An obvious candidate is peripheral GLP-1, which may 
modulate feeding behavior by acting directly on GLP-1 
receptors in the CNS (8) or, hypothetically, via GLP-1 
receptors on vagal afferents. 
An analogy may be drawn between the effect of 
GLP-1 in the present study and that of peripheral 
administration of the satiety hormone (30), cholecysto- 
kinin octapeptide (CCK-8), in other studies. Both pep- 
tides elicit elevated c-FL1 in the NTS, AP, l-PBN, PVN, 
and 1-CeA (present results, 3, 13, 27). Although some 
differences exist between c-FL1 after peripheral admin- 
istration of CCK-8 (supraoptic nucleus) and i3vt admin- 
istration of GLP-1 (Arc), the present data are consistent 
with the possibility that GLP-1 and CCK influence food 
intake similarly. Alternatively, i3vt GLP-1 may reduce 
food intake via a nonspecific effect because the pattern 
of c-FL1 after i3vt GLP-1 (NTS, AP, l-PBN, CeA) also 
resembles the pattern that is expressed after adminis- 
tration of the emetic agent, lithium chloride (25). 
Perspectives 
The present results demonstrate that two treatments 
that reduce food intake equivalently can induce consid- 
erably different patterns of neuronal activation. Such a 
result implies that the function of these two endog- 
enous peptides in the control of food intake may also be 
quite different. Because the levels of leptin in the 
plasma appear not to change acutely with the consump- 
tion of meals (2, 15), leptin would appear not to be a 
good candidate for regulating the termination of inges- 
tive bouts. GLP-1 levels in the periphery, however, are 
elevated in response to food consumption (8, lo), and 
consequently the possibility remains that peripheral or 
central GLP-1 may be involved in meal termination. 
Additionally, whereas leptin administration has a po- 
tent inhibitory effect on long-term food intake and body 
weight (1, 5, 19, 29), there are no data of which we are 
aware that GLP-1 administration can inhibit long-term 
food intake or body weight. This supports the hypoth- 
esis that, whereas leptin is a body weight regulatory 
factor, GLP-1 may inhibit food intake only in the short 
term. The different patterns of c-FL1 may reflect these 
different roles. Body weight regulatory factors, like 
leptin, activate primarily forebrain (e.g., hypothalamic 
and limbic) circuits, whereas compounds that regulate 
meal termination, such as CCK, bombesin-like pep- 
tides, and GLP-1 activate a number of caudal brain 
stem as well as forebrain circuits. 
This study was supported by grants from the Dutch Diabetes 
Association (to G. van Dijk) and National Institutes of Health Grants 
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R. J. Seeley), and DC-00248 (to I. L. Bernstein). 
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